Prescribing of disease modifying agents in older adults with multiple sclerosis

Multiple Sclerosis and Related Disorders(2022)

Cited 2|Views8
No score
Abstract
•Only one in five older adults with multiple sclerosis (MS) were prescribed disease modifying agents (DMAs).•Injectable DMAs are widely used among older adults, followed by orals and then infusions.•Various demographic and clinical factors were associated with the selection of DMAs.
More
Translated text
Key words
Multiple sclerosis,Older adults,Secondary progressive MS,Disease-modifying agents,Prescribing patterns,Healthcare resource utilization
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined